Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Vecchi, M. L.
Right arrow Articles by Sinico, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vecchi, M. L.
Right arrow Articles by Sinico, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 1600-1603
© 2000 European Renal Association-European Dialysis and Transplant Association

Anti-laminin auto antibodies in ANCA-associated vasculitis

Maurizio Li Vecchi1,, Antonella Radice2, Fabrizio Renda1, Giuseppe Mulé1 and Renato A. Sinico2

1 Istituto di Clinica Medica e Malattie Cardiovascolari, Cattedra di Nefrologia, Università di Palermo, Palermo, and 2 Dipartimenti di Nefrourologia e di Allergologia e Immunologia Clinica, Azienda Ospedaliera Ospedale San Carlo Borromeo, Milano, Italia

Background. Endothelial cell damage occurs during vasculitic processes in vivo. With the alteration of the endothelium, exposure to basement membrane components may occur with induction of humoral immunity.

Methods. In the present study, we evaluated the prevalence of antibodies against the basement membrane antigen laminin (LMN) in patients with ANCA-associated systemic vasculitis (AASV), pathologic controls (systemic lupus erythematosus, mixed cryoglobulinaemia, Henoch–Schönlein purpura, primary glomerulonephritis) and normal individuals.

Results. By ELISA, 21.6% of AASV (16/74) and 10% of pathologic controls (3/30), but only one of the normal controls (2.8%) had these antibodies (P=0.02). When AASV patients were divided into two groups according to diagnosis and ANCA antigen specificity, antibodies to LMN were found in 27.5% of MPO-ANCA positive microscopic polyangiitis patients (11/40) vs only 14.7% of PR3-ANCA positive Wegener granulomatosis patients (5/34). There was no correlation between the presence or titre of anti-LMN antibodies and the main clinical and laboratory parameters.

Conclusion. These results indicate that basement membrane antigens may become immunogenic in patients with AASV, especially in those with MPO-ANCA positivity. These antibodies are most likely the result of endothelial damage secondary to the initial inflammatory process but may well perpetuate further vascular damage in some patients.

Keywords: anti-laminin antibodies; antineutrophil cytoplasmic antibodies; vasculitis

Correspondence and offprint requests to: Prof. Maurizio Li Vecchi, Istituto di Clinica Medica e Malattie Cardiovascolari, Cattedra di Nefrologia, Via del Vespro, 129, I-90127 Palermo, Italy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.